|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Feb 28, 2025
|
FY2024
12 months to Feb 29, 2024
|
FY2023
12 months to Dec 31, 2022
|
FY2022
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue (exclusive of depreciation and amortization, shown separately below) | |||||
| Gross profit | |||||
| Operating Expenses | |||||
| Salaries and benefits | |||||
| Allocation share based compensation expense | |||||
| General and administrative | |||||
| Sales and marketing | |||||
| Professional service fees | |||||
| Technology | |||||
| Organization costs | |||||
| Depreciation and amortization | |||||
| Asset impairment charge | |||||
| Provision for credit loss | |||||
| Other operating expenses | |||||
| Total Operating Expenses | |||||
| Operating loss | |||||
| Other Income/(Expenses) | |||||
| Loss on disposal of assets | |||||
| Gain on derivative liability | |||||
| Loss on extinguishment of liability | |||||
| Loss on promissory note receivable | |||||
| Interest income (expense), net | |||||
| Other Income (expense) | |||||
| Total other income (expense) | |||||
| Net loss from continuing operations before taxes | |||||
| Net loss from continuing operations before share of net income (loss) in equity method investee | |||||
| Share of net loss of equity method investee | |||||
| Net loss from continuing operations | |||||
| Net gain (loss) from discontinued operations, net of taxes | |||||
| Net loss | |||||
| Preferred Dividends | |||||
| Net Loss Applicable to Common Stockholders | |||||
| Basic loss per common share from continuing operations | |||||
| Diluted loss per common share from continuing operations | |||||
| Basic loss per common share from discontinued operations | |||||
| Diluted loss per common share from discontinued operations | |||||
| Loss per common share basic | |||||
| Loss per common share diluted | |||||
| Weighted average number of shares outstanding basic | |||||
| Weighted nverage number of shares outstanding diluted | |||||
Loading...